Table 5.
Key Findings on Metabolic Biomarkers in Patients with FS
| Author | Biomarker | FSG value* | CG value* | p value |
|---|---|---|---|---|
| Salek et al. [27] | Glucose | 7.25 ± 0.96 | 6.67 ± 0.76 | p = 0.012 |
| HbA1 C | 7.15 ± 0.77 | 6.77 ± 0.51 | p = 0.028 | |
| Triglycerides | 200.13 ± 21.26 | 144.03 ± 12.58 | p < 0.001 | |
| Sung et al. [33] | Cholesterol | 199.2 ± 37.2 | 186.5 ± 36.3 | p < 0.05 |
| Triglyceride | 100.0 (78.0 to 145.8) | 101.0 (73.0 to 147.0) | p < 0.05 | |
| Schiefer et al. [34] | TSH | 2.3 ± 1.5 | 2.2 ± 1.9 | p = 0.124 |
| F-T4 | 1.2 ± 0.4 | 1.1 ± 0.2 | p = 0.124 | |
| Hypothyroidism | 27.2 ± 25 | 10.7 ± 16 | p = 0.001 | |
| Safran et al. [35] | Fasting Glucose | 4.5 ± 0.7 | p > 0.5 | |
| Glucose after 2 h | 5.5 ± 1.5 | p > 0.5 | ||
| Chan et al. [36] | Hypothyroidism | 30.4 ± 6.4 | 10.7 ± 16 | p = 0.29 |
| HBA1 C | 7.75 ± 2.13 | 6.91 ± 1.98 | p = 0.29 | |
| Park et al. [39] | Cholesterol | 203.1 ± 36.2 | 198.1 ± 35.1 | p < 0.022 |
| LDL | 132.8 ± 32.1 | 129.7 ± 31.5 | p < 0.022 | |
| Triglycerides | 122.0 ± 77.1 | 119.6 ± 61.2 | p < 0.030 | |
| HDL | 59.6 ± 11.2 | 61.2 1 ± 6.8 | p < 0.022 | |
| Non-HDL | 141.8 ± 28.6 | 137.6 ± 32.6 | p < 0.022 | |
| HbA1 C | 5.48 ± 0.35 | 5.4 ± 0.33 | p < 0.030 | |
| Mertents et al. [40] | HbA1 C | 5.28 ± 0.68 | 4.86 ± 0.36 | P = 0.0056 |
| Chen B et al. [41] | Glucose | 1.11 | 1.69 | P = 0.003 |
Abbreviations: FSG Frozen shoulder group, CG Control group, HbA1 C Hemoglobin A1c, TSH Thyroid Stimulating Hormone, F-T4 Free Thyroxine, LDL Low-Density Lipoprotein, HDL High-Density Lipoprotein, Non-HDL Non-High-Density Lipoprotein
*Data are expressed as mean ± SD (standard deviation)